Anta L - Search Results

1

Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM.

Litman R, Naber D, Anta L, Martínez J, Filts Y, Correll CU. Litman R, et al. Among authors: anta l. Neuropsychiatr Dis Treat. 2023 Jan 25;19:219-232. doi: 10.2147/NDT.S392351. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 36721796 Free PMC article.

2

Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study.

Filts Y, Litman RE, Martínez J, Anta L, Naber D, Correll CU. Filts Y, et al. Among authors: anta l. Schizophr Res. 2022 Jan;239:83-91. doi: 10.1016/j.schres.2021.11.030. Epub 2021 Nov 27. Schizophr Res. 2022. PMID: 34847501 Free article. Clinical Trial.

3

A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia.

Anta L, Llaudó J, Ayani I, Martínez J, Litman RE, Gutierro I. Anta L, et al. Int Clin Psychopharmacol. 2018 Mar;33(2):79-87. doi: 10.1097/YIC.0000000000000203. Int Clin Psychopharmacol. 2018. PMID: 29112001 Clinical Trial.

4

Corrigendum to "Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study" [Schizophr. Res. 239 (2022) 83-91].

Filts Y, Litman RE, Martínez J, Anta L, Naber D, Correll CU. Filts Y, et al. Among authors: anta l. Schizophr Res. 2022 Aug;246:258-259. doi: 10.1016/j.schres.2022.06.037. Epub 2022 Jul 16. Schizophr Res. 2022. PMID: 35853294 No abstract available.

5

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study.

Walling DP, Hassman HA, Anta L, Ochoa L, Ayani I, Martínez J, Gutierro I. Walling DP, et al. Among authors: anta l. Drug Des Devel Ther. 2021 Oct 15;15:4371-4382. doi: 10.2147/DDDT.S332026. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34703212 Free PMC article.

6

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRISMA-1).

Llaudó J, Anta L, Ayani I, Martínez J, Schronen J, Morozova M, Ivanov M, Gutierro I. Llaudó J, et al. Among authors: anta l. Int Clin Psychopharmacol. 2016 Nov;31(6):323-31. doi: 10.1097/YIC.0000000000000139. Int Clin Psychopharmacol. 2016. PMID: 27416102 Clinical Trial.

7

Newer Formulations of Risperidone: Remarks About Risperidone ISM^®.

Anta L, Mata E, Ochoa Díaz de Monasterioguren L. Anta L, et al. CNS Drugs. 2020 Oct;34(10):1087-1088. doi: 10.1007/s40263-020-00762-0. CNS Drugs. 2020. PMID: 32892315 No abstract available.

8

Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.

Poveda E, Anta L, Blanco JL, Pérez-Elías MJ, García F, Leal M, Ribera E, Gutiérrez F, Soriano V, de Mendoza C; Resistance Platform of the Spanish AIDS Research Network (ResRIS). Poveda E, et al. Among authors: anta l. AIDS. 2010 Jan 28;24(3):469-71. doi: 10.1097/QAD.0b013e328331a4b8. AIDS. 2010. PMID: 20057310

9

Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain.

Treviño A, Soriano V, Rodríguez C, Arredondo M, Rivas P, Herrero-Mendoza D, Parra P, del Romero J, Anta L, Puente S, de Mendoza C. Treviño A, et al. Among authors: anta l. AIDS Res Hum Retroviruses. 2011 Jun;27(6):633-8. doi: 10.1089/AID.2010.0247. Epub 2010 Dec 6. AIDS Res Hum Retroviruses. 2011. PMID: 21039316

10

Assessment of beliefs and attitudes about electroconvulsive therapy posted on Twitter: An observational study.

de Anta L, Alvarez-Mon MA, Donat-Vargas C, Lara-Abelanda FJ, Pereira-Sanchez V, Gonzalez Rodriguez C, Mora F, Ortega MA, Quintero J, Alvarez-Mon M. de Anta L, et al. Eur Psychiatry. 2023 Jan 9;66(1):e11. doi: 10.1192/j.eurpsy.2022.2359. Eur Psychiatry. 2023. PMID: 36620994 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page